https://orcid.org/0000-0002-8156-5649
Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Praveen Kesav, Divya Manesh Raj & Seby John. (2023) Cerebrovascular Fibromuscular Dysplasia – A Practical Review. Vascular Health and Risk Management 19, pages 543-556.
Read now
Read now
William David Wells-Gatnik, Tiffany Yazmin Wences Chirino, Fatma Nur Onan, Dilara Onan & Paolo Martelletti. (2023) Emerging experimental drugs in clinical trials for migraine: observations and key talking points. Expert Opinion on Investigational Drugs 32:8, pages 761-771.
Read now
Read now
Fred Cohen & Hsiangkuo Yuan. (2022) Role of Atogepant in the Treatment of Episodic Migraines: Clinical Perspectives and Considerations. Therapeutics and Clinical Risk Management 18, pages 447-456.
Read now
Read now
Brandon S Baksh, Julia Costa Garcia & Anat Galor. (2021) Exploring the Link Between Dry Eye and Migraine: From Eye to Brain. Eye and Brain 13, pages 41-57.
Read now
Read now
Laurent David, Michelle Scalley-Kim, Andrea Olland, Andre White & Kira Misura. (2021) The eptinezumab:CGRP complex structure – the role of conformational changes in binding stabilization. Bioengineered 12:2, pages 11076-11086.
Read now
Read now
Articles from other publishers (43)
Lanfranco Pellesi. (2023) Editorial: Novel migraine therapies: consolidating evidence from the real world. Frontiers in Pain Research 4.
Crossref
Crossref
Yan Tereshko, Simone Dal Bello, Sara Pez, Enrico Belgrado, Christian Lettieri, Bruno Hector Ercole, Giulia Cellante, Caterina Del Regno, Giuseppe Sportelli, Giovanni Ermanis, Salvatore Versace, Giovanni Merlino, Gian Luigi Gigli & Mariarosaria Valente. (2023) Comparative Study of the Efficacy of Anti-CGRP mAbs on Migraineurs: Analysis of the First Year of Therapy, 1-Month Suspension Period, and Reprisal. Journal of Clinical Medicine 12:23, pages 7329.
Crossref
Crossref
Carmen Sánchez-Rodríguez, Ana Beatriz Gago-Veiga, David García-Azorín, Ángel Luis Guerrero-Peral & Alicia Gonzalez-Martinez. (2023) Potential Predictors of Response to CGRP Monoclonal Antibodies in Chronic Migraine: Real-World Data. Current Pain and Headache Reports.
Crossref
Crossref
Yulong Chen, Qingzhou Cheng, Shan Zeng & Site Lv. (2023) Potential analgesic effect of Foshousan oil-loaded chitosan-alginate nanoparticles on the treatment of migraine. Frontiers in Pharmacology 14.
Crossref
Crossref
Seyed-Amirabbas Ahadiat & Zeinab Hosseinian. (2023) Progress in treating migraines: promising prospects for a better tomorrow. Bulletin of the National Research Centre 47:1.
Crossref
Crossref
Ja Bin Hong, Kristin Sophie Lange, Lucas Hendrik Overeem, Paul Triller, Bianca Raffaelli & Uwe Reuter. (2023) A Scoping Review and Meta-Analysis of Anti-CGRP Monoclonal Antibodies: Predicting Response. Pharmaceuticals 16:7, pages 934.
Crossref
Crossref
Spogmay Anwar, Arif-ullah Khan & Nadeem Irshad. (2023) Pharmacological evaluation of carvacrol anti-migraine potential. Naunyn-Schmiedeberg's Archives of Pharmacology 396:6, pages 1309-1324.
Crossref
Crossref
Yan Li, Xinghe Wang, Alex Ballesteros‐Perez, Richard Bertz & Zhihong Lu. (2023) Pharmacokinetics and Safety of Single and Multiple Daily Dosing of 75‐mg Rimegepant Orally Disintegrating Tablets in Healthy Chinese Adults: A Randomized Placebo‐Controlled Trial. Clinical Pharmacology in Drug Development 12:6, pages 594-601.
Crossref
Crossref
Mingxue Wang, Yujia Gu, Shuhan Meng, Lixin Kang, Jing Yang, Degang Sun, Yuxing Liu, Ze Wan, Yi Shan, Dongjie Xue, Chang Su, Shufen Li, Ran Yan, Yu Liu, Yashuang Zhao & Yonghui Pan. (2023) Association between TRP channels and glutamatergic synapse gene polymorphisms and migraine and the comorbidities anxiety and depression in a Chinese population. Frontiers in Genetics 14.
Crossref
Crossref
Xiaoting Lv, Qingquan Chen, Zewei Zhang, Kaili Du, Yaping Huang, Xingzhe Li & Yiming Zeng. (2023) αCGRP deficiency aggravates pulmonary fibrosis by activating the PPARγ signaling pathway. Genes & Immunity 24:3, pages 139-148.
Crossref
Crossref
Michele Torrisi, Francesco Corallo, Viviana Lo Buono, Marcella Di Cara, Rosario Grugno, Riccardo Lo Presti, Angelo Quartarone & Maria Cristina De Cola. (2023) Migraine Treatment Using Erenumab: Can Lead to a Cognitive and Psychological Qualitative Improvement?. Medicina 59:5, pages 936.
Crossref
Crossref
Cinder Faith Cohen, Jueun Roh, Sang Hoon Lee, Chul-Kyu Park & Temugin Berta. (2023) Targeting Nociceptive Neurons and Transient Receptor Potential Channels for the Treatment of Migraine. International Journal of Molecular Sciences 24:9, pages 7897.
Crossref
Crossref
Mohammad Al-Mahdi Al-Karagholi. (2023) Involvement of Potassium Channel Signalling in Migraine Pathophysiology. Pharmaceuticals 16:3, pages 438.
Crossref
Crossref
Wei Ning, Ge Gao, Yong Zhou, Wen-qun Li, Hui-hui Yang, Xiang-bing Duan, Xin Li, Yi-bo Gong, Dai Li & Ren Guo. (2023) Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation. International Immunopharmacology 116, pages 109747.
Crossref
Crossref
Wensheng Lin, Shixian Lin, Xingwu Zhou, Fanwen Yang, Zishan Lin, Shiqing Li, Haoyuan Zhang, Yuehan Ouyang, Jieying Zhu, Wei Sun, Dequn Huang, Baojian Liao & Jixiang Zhu. (2023) Biodegradable double-network GelMA-ACNM hydrogel microneedles for transdermal drug delivery. Frontiers in Bioengineering and Biotechnology 11.
Crossref
Crossref
Dax Abraham, Arundeep Singh & Anjana Goyal. (2023) Gingival crevicular fluid levels of neurokinin A and substance P in patients with symptomatic irreversible pulpitis: A systematic review and meta-analysis. Journal of International Society of Preventive and Community Dentistry 13:4, pages 307-317.
Crossref
Crossref
Ilana B. Kotliar, Emily Lorenzen, Jochen M. Schwenk, Debbie L. Hay & Thomas P. Sakmar. (2023) Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins. Pharmacological Reviews 75:1, pages 1-34.
Crossref
Crossref
Xiaoyan Bai, Wei Wang, Xueyan Zhang, Zhangxuan Hu, Yingkui Zhang, Zhiye Li, Xue Zhang, Ziyu Yuan, Hefei Tang, Yaqing Zhang, Xueying Yu, Peng Zhang, Yonggang Wang & Binbin Sui. (2022) Cerebral perfusion variance in new daily persistent headache and chronic migraine: an arterial spin-labeled MR imaging study. The Journal of Headache and Pain 23:1.
Crossref
Crossref
Sanne Hage La Cour, Kiki Juhler, Lisette J. A. Kogelman, Jes Olesen, Dan Arne Klærke, David Møbjerg Kristensen & Inger Jansen-Olesen. (2022) Characterization of erenumab and rimegepant on calcitonin gene-related peptide induced responses in Xenopus Laevis oocytes expressing the calcitonin gene-related peptide receptor and the amylin-1 receptor. The Journal of Headache and Pain 23:1.
Crossref
Crossref
Amnon A. Berger, Ariel Winnick, Austin H. Carroll, Alexandra Welschmeyer, Nathan Li, Marc Colon, Antonella Paladini, Giovanni F. Ramírez, Jamal Hasoon, Elyse M. Cornett, Jaehong Song, Giustino Varrassi, Adam M. Kaye, Alan D. Kaye & Latha Ganti. (2022) Rimegepant for the treatment of migraine. Health Psychology Research 10:5.
Crossref
Crossref
Ashley Holdridge, Jennifer Buczyner, Cristina Cabret Aymat & Ariel Le. (2022) Prevention of Migraine. Seminars in Neurology 42:05, pages 558-570.
Crossref
Crossref
Ti Li, Shupeng Guo, Meixi Lu, Fang Lu, Tianjiao Lu & Chunze Zheng. (2022) Exploring the pharmacological action mechanism of Ligusticum Chuanxiong-Piper Longum couplet medicines on the treatment of migraine based on network pharmacology. Frontiers in Pharmacology 13.
Crossref
Crossref
Qian Wang, Jianlin Han, Alexander Sorochinsky, Aitor Landa, Greg Butler & Vadim A. Soloshonok. (2022) The Latest FDA-Approved Pharmaceuticals Containing Fragments of Tailor-Made Amino Acids and Fluorine. Pharmaceuticals 15:8, pages 999.
Crossref
Crossref
Brandon J. Rea, Abigail Davison, Martin-Junior Ketcha, Kylie J. Smith, Aaron M. Fairbanks, Anne-Sophie Wattiez, Pieter Poolman, Randy H. Kardon, Andrew F. Russo & Levi P. Sowers. (2022) Automated detection of squint as a sensitive assay of sex-dependent calcitonin gene–related peptide and amylin-induced pain in mice. Pain 163:8, pages 1511-1519.
Crossref
Crossref
Jennifer Robblee & Lauren K. Harvey. (2022) Cardiovascular Disease and Migraine: Are the New Treatments Safe?. Current Pain and Headache Reports 26:8, pages 647-655.
Crossref
Crossref
Messoud Ashina, Michel Lanteri-Minet, Patricia Pozo-Rosich, Anders Ettrup, Cecilie Laurberg Christoffersen, Mette Krog Josiassen, Ravinder Phul & Bjørn Sperling. (2022) Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial. The Lancet Neurology 21:7, pages 597-607.
Crossref
Crossref
Michal Fila, Anna Sobczuk, Elzbieta Pawlowska & Janusz Blasiak. (2022) Epigenetic Connection of the Calcitonin Gene-Related Peptide and Its Potential in Migraine. International Journal of Molecular Sciences 23:11, pages 6151.
Crossref
Crossref
Kumiko Ishida, Satoshi Tanaka, Dandan Shen, Shuhei Matsui, Satoshi Fuseya, Takayuki Shindo & Mikito Kawamata. (2022) Calcitonin gene-related peptide is not involved in neuropathic pain induced by partial sciatic nerve ligation in mice. Neuroscience Letters 778, pages 136615.
Crossref
Crossref
Fred Cohen, Hsiangkuo Yuan, E. M. G. DePoy & Stephen D. Silberstein. (2022) The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine. Neurotherapeutics 19:3, pages 922-930.
Crossref
Crossref
Dingding Liu, Lulu Chang, Jingru Wang, Qiang Zhu, Ning Jiang, Mudassar Azhar, Ayaz Ahmed & Guirong Zeng. (2022) Effect of Xiongmatang Extract on Behavioral and TRPV1-CGRP/CGRP-R Pathway in Rats With Migraine. Frontiers in Pharmacology 13.
Crossref
Crossref
Ambrish Kumar, Maelee Williamson, Andrew Hess, Donald J. DiPette & Jay D. Potts. (2022) Alpha-Calcitonin Gene Related Peptide: New Therapeutic Strategies for the Treatment and Prevention of Cardiovascular Disease and Migraine. Frontiers in Physiology 13.
Crossref
Crossref
Fatemeh Ramezani, Ali Neshasteh-Riz, Alireza Ghadaksaz, Seyedalireza Moghadas Fazeli, Atousa Janzadeh & Michael R. Hamblin. (2021) Mechanistic aspects of photobiomodulation therapy in the nervous system. Lasers in Medical Science 37:1, pages 11-18.
Crossref
Crossref
Xiaoting Lv, Qingquan Chen, Shuyu Zhang, Feng Gao & Qicai Liu. (2022) CGRP: A New Endogenous Cell Stemness Maintenance Molecule. Oxidative Medicine and Cellular Longevity 2022, pages 1-16.
Crossref
Crossref
N. V. Vashchenko, A. M. Uzhakhov, M. V. Bogorodskaya, D. Z. Korobkova, Ju. E. Azimova & K. V. Skorobogatykh. (2022) Six-month therapy of CGRP monoclonal antibodies in real-world clinical practice: an interim analysis of efficacy and safety data. Meditsinskiy sovet = Medical Council:21-1, pages 64-70.
Crossref
Crossref
Abubker Omaer, Fahad M. Aldosari, Emily McGlamery, Saad Alrashed, Steven Wool & Maryam T. Fazel. (2021)
Retracted:
Calcitonin Gene‐Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information
. Journal of Clinical Pharmacy and Therapeutics 47:1.
Crossref
Crossref
Luigi Francesco Iannone, Francesco De Logu, Pierangelo Geppetti & Francesco De Cesaris. (2022) The role of TRP ion channels in migraine and headache. Neuroscience Letters 768, pages 136380.
Crossref
Crossref
Pei Feng Lim, Scott De Rossi & Massimiliano Di Giosia. 2021. Burket's Oral Medicine. Burket's Oral Medicine
453
467
.
Ana Recober. (2021) Pathophysiology of Migraine. CONTINUUM: Lifelong Learning in Neurology 27:3, pages 586-596.
Crossref
Crossref
Olivia C. Eller, Xiaofang Yang, Isabella M. Fuentes, Angela N. Pierce, Brittni M. Jones, Aaron D. Brake, Ruipeng Wang, Gregory Dussor & Julie A. Christianson. (2021) Voluntary Wheel Running Partially Attenuates Early Life Stress-Induced Neuroimmune Measures in the Dura and Evoked Migraine-Like Behaviors in Female Mice. Frontiers in Physiology 12.
Crossref
Crossref
Anne-Sophie Wattiez, William C. Castonguay, Olivia J. Gaul, Jayme S. Waite, Chantel M. Schmidt, Alyssa S. Reis, Brandon J. Rea, Levi P. Sowers, Coral J. Cintrón-Pérez, Edwin Vázquez-Rosa, Andrew A. Pieper & Andrew F. Russo. (2021) Different forms of traumatic brain injuries cause different tactile hypersensitivity profiles. Pain 162:4, pages 1163-1175.
Crossref
Crossref
Mengya Wang, Anne-Sophie Wattiez & Andrew F. Russo. 2021. Monoclonal Antibodies in Headache. Monoclonal Antibodies in Headache
69
97
.
Hui Zhang, Xue‐mei Zhang, Dan‐dan Zong, Xiao‐ying Ji, Hua Jiang, Feng‐zheng Zhang & Sheng‐dong He. (2020) miR‐34a‐5p up‐regulates the IL‐1β/COX2/PGE2 inflammation pathway and induces the release of CGRP via inhibition of SIRT1 in rat trigeminal ganglion neurons. FEBS Open Bio 11:1, pages 300-311.
Crossref
Crossref
Levi P. Sowers, Mengya Wang, Brandon J. Rea, Rebecca J. Taugher, Adisa Kuburas, Youngcho Kim, John A. Wemmie, Christopher S. Walker, Debbie L. Hay & Andrew F. Russo. (2020) Stimulation of Posterior Thalamic Nuclei Induces Photophobic Behavior in Mice. Headache: The Journal of Head and Face Pain 60:9, pages 1961-1981.
Crossref
Crossref